COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Announcement on Resolutions of the Third Meeting of the Fifth Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd.
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-030
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on Resolutions of the Third Meeting of the Fifth Board of Directors
The third meeting of the fifth session of the Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”) was held on August 16, 2013 by means of communication voting. The meeting was notified by telephone, email on August 6, 2013. In the same way, the meeting should be attended by 7 directors and 7 actual attendees. The convening of this meeting is in line with the relevant provisions of the Company Law and the Articles of Association. The convening procedures and voting results of this meeting are legal and valid. After careful consideration by the attending directors, the following proposals were passed:
Reviewed and passed the "Proposal on Applying for Working Capital Loans to China Construction Bank Co., Ltd. Tonghua Branch"
The result of the review: 7 votes in favor, 0 votes against, and 0 abstentions.
1. Apply to the China Construction Bank Co., Ltd. Tonghua Branch for a working capital loan of no more than RMB 300 million for the procurement of raw materials. The loan period is one year.
2. The guarantee method of the above loan is stock pledge, and the company's controlling shareholder Dunhua Kangping Investment Co., Ltd. holds the unrestricted shares of the company as pledge.
3. Authorized financial manager Shao Tianyu has full authority to handle the loan procedures.
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
August 17, 2013